Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for generalized anxiety disorder
IRCT20150706023083N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine in generalized anxiety disorder (GAD) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Anxiety score. Started Jul 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on IRCT20150706023083N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023083N5.